From Nasdaq:

Generative AI is rapidly transforming healthcare, with the global market projected to grow at a CAGR of 36.7% from 2023 to 2030. It has the potential to improve patient care, drug discovery, and overall healthcare delivery by analyzing data, improving imaging, and predicting results. Investors should keep an eye on Medtronic Plc MDT, Stryker Corporation SYK, and NVIDIA Corporation NVDA for solid returns from this market.

Generative AI in healthcare is revolutionizing patient care, cost reduction, and business efficiency. AI-powered chatbots can provide tailored assistance to patients, while advancements in medical imaging are being made in areas such as radiology and pathology. The global market presents significant opportunities for further growth and development.

Medtronic Plc is leveraging AI and machine learning to improve patient outcomes and reduce healthcare costs. The company is leading the way in spine intelligence and recently expanded its partnership with Cosmo Intelligent Medical Devices to advance the use of AI in endoscopic care. Stryker Corporation also uses AI and machine learning to enhance patient outcomes and efficiency in surgical planning, medical imaging, and more. Their Mako robotic surgery platform has seen record-breaking installations in recent years. NVIDIA Corporation, meanwhile, is gaining from the strong growth of AI, high-performance computing, and accelerated computing. The company’s GPUs are rapidly benefiting from the proliferation of AI in untapped markets like automotive, healthcare, and manufacturing.

Investors should consider tapping into the rising prospects of the generative AI in the healthcare market. Now is the ideal time to invest in companies like Medtronic, Stryker, and NVIDIA that are leveraging AI to transform patient care, business efficiency, and overall healthcare delivery.



Read more: Generative AI Reshapes Healthcare: 3 Stocks in Limelight